Alex Gorsky, Chief Executive Officer of Johnson & Johnson Photo: FoxNews

COVID-19 Vaccine boosters for immunised consumers may be needed for years ─J&J CEO

*Chief Executive Officer of Johnson & Johnson (J&J), Alex Gorsky, restates that protection from current Coronavirus vaccinations will diminish over time, and there is most likely need for additional COVID-19 vaccinations in the foreseeable future until ‘global herd immunity’ is attained

Alexander Davis | ConsumerConnect

As they say, that ‘it is not over until it is over,’ regarding how some regions of the global community have been immunised already, while several other developing countries and emerging markets are yet to get inoculated against the damaging Coronavirus (COVID-19) pandemic.

Alex Gorsky, Chief Executive Officer (CEO) of Johnson & Johnson (J&J) has reiterated his company’s position, that consumers who are immunised against the pandemic already yet will most likely need additional COVID-19 vaccinations for the foreseeable future.

Gorsky, who said this when speaking at The Wall Street Journal’s Tech Health conference Wednesday, June 9, 2021, repeated the booster shots would likely be essential until global herd immunity is accomplished, and all of the riskier variants are contained.

The J&J CEO’s comments reportedly emanated on the heels of American scientist Dr. Anthony Fauci reminding Americans to get vaccinated to keep the Delta variant from spreading across the Unired States (US).

Why do people need a vaccine booster?

Again, Gorsky stated the protection provided by approved COVID-19 vaccines is probably enough for ‘the time being’, but he noted that their effectiveness will diminish over time.

“We could be looking at this tagging along with the flu shot, likely over the next several years,” he said.

It is also noted that Ugur Sahin, CEO of the German biotech firm BioNTech, told CNBC in a recent interview, that researchers are seeing a decline in antibody responses against the virus after eight months.

Report said the company anticipated this situation back in December 2020, when it broached that it could create a vaccine for new Coronavirus variants in six weeks, if necessary.

Kindly Share This Story